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Abstract
Background: Campylobacter jejuni is the leading bacterial cause of human gastroenteritis in the
developed world. To improve our understanding of this important human pathogen, the C. jejuni
NCTC11168 genome was sequenced and published in 2000. The original annotation was a
milestone in Campylobacter research, but is outdated. We now describe the complete re-
annotation and re-analysis of the C. jejuni NCTC11168 genome using current database information,
novel tools and annotation techniques not used during the original annotation.
Results: Re-annotation was carried out using sequence database searches such as FASTA, along
with programs such as TMHMM for additional support. The re-annotation also utilises sequence
data from additional Campylobacter strains and species not available during the original annotation.
Re-annotation was accompanied by a full literature search that was incorporated into the updated
EMBL file [EMBL: AL111168]. The C. jejuni NCTC11168 re-annotation reduced the total number
of coding sequences from 1654 to 1643, of which 90.0% have additional information regarding the
identification of new motifs and/or relevant literature. Re-annotation has led to 18.2% of coding
sequence product functions being revised.
Conclusions: Major updates were made to genes involved in the biosynthesis of important surface
structures such as lipooligosaccharide, capsule and both O- and N-linked glycosylation. This re-
annotation will be a key resource for Campylobacter research and will also provide a prototype for
the re-annotation and re-interpretation of other bacterial genomes.
Background
Campylobacter jejuni is the leading bacterial cause of
human gastroenteritis in the developed world [1]. C.
jejuni infection has also been associated with post-infec-
tion sequelae including septicaemia and neuropathies
such as Guillain-Barré Syndrome (GBS) [2]. Infection has
largely been linked with the consumption of contami-
nated poultry or meat products. Given the socioeconomic
importance of this pathogen, it is surprising that the ecol-
ogy, the epidemiology and, in particular, the pathogenesis
are still so poorly understood [3]. The lack of information
on this problematic pathogen was one of the main driving
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forces for the original C. jejuni NCTC11168 genome
project published in 2000 [4], and equally is why a re-
annotation and re-analysis of the genome is required.
Since the publication of the C. jejuni NCTC11168 genome
sequence in 2000, there has been a spectacular increase in
research on this important human pathogen. One result
of this has been significant revisions of the genetic loci
that code for important surface structures on C. jejuni
strains. The surface polysaccharide region has since been
identified as a capsule locus (Cj1413c – Cj1448c) [5-7].
The flagellar modification locus has been identified as an
O-linked glycosylation pathway (Cj1293 – Cj1342) [8-
11]. Progress has also been made in our understanding of
the lipooligosaccharide (LOS) locus. In addition, the N-
linked glycosylation pathway has been identified in C.
jejuni (Cj1119 – Cj1130) [9,12-14]. This N-linked general
glycosylation system was initially thought to only be
present in eukaryotes. To date, up to 30 proteins modified
with the same heptasaccharide glycan structure have been
identified. Research over the last 7 years on C. jejuni, cou-
pled with the publication of a further 2 C. jejuni genome
sequences [15,16] and another 3 Campylobacter species
[15], has heightened the need for re-analysis of the origi-
nal NCTC11168 genome sequence.
Re-annotation is defined as the process of annotating a
previously annotated genome [17]. Examples of re-anno-
tated genomes are unfortunately rare compared to the
number of sequenced genomes [18,19]. Clearly the ever-
increasing number of new genome sequences requires pri-
oritisation from annotators. Automated methods can save
time and resources, but will not incorporate the maxi-
mum information available from expert curators, leading
to incomplete or even false designations. By contrast,
manual annotation is costly and time consuming. How-
ever, manual re-annotation of genomes can significantly
reduce the perpetuation of errors and thus reduce the time
spent on flawed research. Outdated annotations can lead
to significant gaps in our knowledge. Hence, there is a
need for a research community-wide review and regular
update of genome interpretations. Here we have shown
the importance of genome re-annotation in terms of
maintaining and increasing the usefulness of this
resource, a number of years after the original genome
sequencing project was completed.
In this study, we describe the re-annotation and re-analy-
sis of the C. jejuni NCTC11168 genome. Manual re-anno-
tation of all coding sequences (CDSs) was carried out
using current annotation techniques. Literature searches,
updates to genome structure and additional unique
genome searches were carried out to produce the most
comprehensive annotation of any Campylobacter genome
to date. The re-annotation of the C. jejuni NCTC11168
genome also represents a useful model for the re-evalua-
tion of other bacterial genomes.
Results & Discussion
Gene number adjustment
A complete re-annotation of the C. jejuni NCTC11168
genome was performed resulting in the reduction of the
total number of CDSs from 1654 to 1643. This reduction
was due to the merging of adjacent CDSs or the removal
of CDSs. Three CDSs originally designated as pseudo-
genes were removed as a result of merging with adjacent
pseudogenes. CDSs designated as pseudogenes were also
updated to reflect the complete amino acid sequence for
the encoded protein regardless of expression. Phase-varia-
ble CDSs that contained an intersecting homopolymeric
region between adjacent CDSs on separate frames were
merged. This allowed the complete amino acid sequence
for appropriate genes to be obtained regardless of phase.
Re-interpretation of phase-variable CDSs resulted in
removal of seven CDSs. CDS (Cj1520) was removed
because of the recently discovered CRISPR structural moi-
eties [20] (See Structural modifications section in Results
& Discussion). In total, 11 CDSs were removed from the
re-annotated sequence (Table 1). The accurate identifica-
tion of all CDSs within the genome has implications for
downstream applications, such as mutagenesis, microar-
ray design and proteome analysis.
Functional annotation update
A systematic re-annotation of all CDSs was performed. For
the purpose of this re-annotation, all CDSs with addi-
tional information have had an 'updated' note qualifier
attached. This qualifier contains consistent free-hand
descriptions on recently identified motifs, relevant simi-
larity search results and any characterisation work carried
out within Campylobacter species/strains or any orthologs
in similar microorganisms. Additionally, the 'updated'
note qualifier also contains reasoning for including 'puta-
tive' or not within the product function. Putative designa-
tions infer an accepted product function without
definitive evidence. For each CDS, a full literature search
was performed. In total, 64.5% of CDSs have had one or
more literature qualifier added. Interestingly, from all the
literature added (2092), 50.5% have been published after
the year 2000. Considering there was no literature quali-
fier in the original annotation, this data illustrates the
depth of research that has been carried out since 2000 and
further supports the need to make use of this information
in a re-annotation. Detailed statistics on genome modifi-
cations are given in Table 2. 18.2% of CDSs have had their
product functions updated. 60.5% of CDSs with new
product function have been designated with a different
functional classification. Additional file 1 gives the out-
line of functional classification used in this annotation.
This description was adopted from the Sanger Institute. A
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different functional classification may still be within the
same field as the previous function, or may be in a com-
pletely new area. 97.8% of these CDSs with a new product
function and a different functional classification were
given a completely new type of functional classification.
Additional file's 2, 3 and 4 give in-depth data on the
change and distribution of CDSs within these functional
categories. Importantly, the number of CDSs in the
'Unknown and other' category has been reduced by 122.
Also, the number of CDSs in the 'Miscellaneous' category
has risen by 77. This is attributed to the fact that a number
of CDSs have new information relating to a product func-
tion from uncharacterised motifs and thus the CDSs were
not placed into a specific category as yet.
Since the original annotation, significant new informa-
tion has been derived on the genetic loci encoding the
four main carbohydrate surface structures. The C. jejuni
N-linked glycosylation pathway (not described in the
original annotation), has been fully characterised [9,12-
14]. This re-annotation includes the nomenclature for the
pglA-K (protein glycosylation) genes and has updated all
product functions for genes Cj1119c – Cj1130c. The LOS
locus (Cj1131c – Cj1152c) described in the original anno-
tation was updated to include recent product functions
and gene names including neuA1, B1, C1 and hldDE [21-
24]. The O-linked glycosylation loci (Cj1293 – Cj1342)
involved in flagellar glycosylation, has been updated to
include neu, pse and maf genes [8-11]. Finally, the capsule
locus (Cj1413c – Cj1448c), has now been updated to
include kps and hdd genes [5-7].
Additional genome-wide updates were also carried out, of
which a large proportion entailed adding specificity to
existing product function. For example, the identification
of a new PFAM or PROSITE motif has allowed the product
function to become further specified e.g. putative trans-
port protein modified to putative MFS (Major Facilitator
System) transport protein. A complete list of changes
throughout the C. jejuni NCTC11168 genome is provided
in Additional File 5.
Pseudogene & phase-variable modification
Pseudogene identification is a challenging process where
discrepancies exist between pseudogene assignment tech-
niques [25]. Identifiers include detection of Open Read-
ing Frames (ORF) belonging to a single CDS on multiple
frames, the presence of one or more stop codon within a
CDS, and extra information from the biology of the
microorganism. More recently, comparative genomics has
been used as a technique for pseudogene assignment [26].
The number of pseudogenes identified in the original
Table 2: Genome wide statistics from C. jejuni NCTC11168 re-annotation.
CDSs with new motifs identified +44.9%
CDSs with new literature qualifier +64.5%
CDSs with new updated note qualifier +90.0%
CDSs with hypothetical designations in product function -7.5%
CDSs with conserved hypothetical in product function +3.7%
CDSs with putative designation in product function +5.9%
CDSs with new gene qualifier +6.3%
CDSs with new product function +18.2%
CDSs with new product function and with a new functional classification +60.5%
CDS with new product function and a new functional classification with a different type of function +97.8%
Table 1: CDSs removed or merged from C. jejuni NCTC11168 re-annotation.
Gene Number Type/Description
Cj0290c/Cj0291c/Cj0292c Pseudogenes
Cj0968/Cj0969 Pseudogenes
Cj0031/Cj0032 Phase-variable
Cj0170/Cj0171 Phase-variable
Cj0628/Cj0629 Phase-variable
Cj1144c/Cj1145c Phase-variable
Cj1325/Cj1326 Phase-variable
Cj1335/Cj1336 Phase-variable
Cj1677/Cj1678 Phase-variable
Cj1520 CRISPR region identified
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annotation of the C. jejuni NCTC11168 genome was 20.
We carried out a re-analysis on all pseudogenes in the
NCTC11168 genome. The majority of revisions we carried
out incorporated multiple features created from different
coordinates on more than one frame. This process is often
complicated with support needed from FASTA and
TBLASTX search results. Completion of this re-analysis
resulted in modification of 19 out of 20 pseudogenes
(Table 3). The final pseudogene number was 19 due to the
merging of two adjacent CDSs designated as pseudogenes
(Cj0968/Cj0969).
An example of the difficulty and complexity associated
with pseudogene designation is observed when viewing
the CDSs Cj0522, Cj0523 and Cj0524 within C. jejuni
NCTC11168. These three CDSs are represented as one
whole CDS on a single frame within C. jejuni RM1221
(Cje0628). The three CDSs are large enough to be repre-
sented as individual CDSs and in C. jejuni NCTC11168
have been represented on more than one frame. The ques-
tion can be asked as to whether these CDSs (which are
intact in C. jejuni RM1221), represent a pseudogene in C.
jejuni NCTC11168. Given the fact that in C. jejuni
RM1221 these three CDSs do actually code for a product
(Na/Pi-cotransporter, putative), it is more likely that they
represent a pseudogene in C. jejuni NCTC11168. In this
re-annotation, our intention was to carry out a full mark
up of existing pseudogenes, however, the potential for a
pseudogene has been noted.
The frequency and importance of pseudogene formation
in microorganisms has attained added significance in
recent years with the emergence of genome reduction the-
ories and enhanced virulence through pathoadaptive
mutations [27,28]. Recent studies have suggested that ever
increasing non-functional genes are being identified
within microorganisms and in particular are more com-
mon in genomes of recently evolved pathogens, than in
their benign or free-living relatives [25]. The number and
type of predicted pseudogenes within C. jejuni
NCTC11168 and C. jejuni RM1221 are compared in Addi-
tional File 6. Observing CDS location rather than CDS
function was carried out for this comparison. This was to
ensure variation in product function naming does not
exclude identical pseudogenes, which are represented on
the same row. Currently, the C. jejuni 81–176 genome has
not been fully annotated so could not be used in this com-
parison. This is also the case for C. coli RM2228, C. lari
RM2100 and C. upsaliensis 3195 which only have an esti-
mation of pseudogene numbers based on a subset of
genes [15]. In C. jejuni NCTC11168, 63% (12/19) of the
pseudogenes are shared with C. jejuni RM1221. In con-
trast to 19 pseudogenes in C. jejuni NCTC11168, C. jejuni
RM1221 contains 47 pseudogenes. Assuming these are
genuine pseudogenes this would imply C. jejuni
NCTC11168 (1980 human isolate, UK) and C. jejuni
RM1221 (2000 chicken isolate, US), share a core set of
ancestral pseudogenes. Even with the variation of isola-
tion dates, source and geographical location, there is sub-
stantial conservation of pseudogene type. It is speculative
to suggest when and how the additional pseudogenes in
C. jejuni RM1221 arose, or when and how the C. jejuni
NCTC11168 genome lost CDSs as pseudogenes since
divergence occurred.
Table 3: Pseudogenes in C. jejuni NCTC11168 with modification.
Gene Number Product Modification
Cj0046 pseudogene (putative sodium:sulfate transmembrane transport protein) Features introduced within CDS
Cj0072c pseudogene (putative iron-binding protein) Features introduced within CDS
Cj0223 pseudogene (putative IgA protease family protein) Features introduced within CDS
Cj0292c pseudogene (putative glycerol-3-phosphate transporter) Merging of multiple CDS
Cj0444 pseudogene (putative TonB-denpendent outer membrane receptor) Features introduced within CDS
Cj0501 pseudogene (ammonium transporter) Features introduced within CDS
Cj0565 pseudogene (conserved hypothetical protein) Features introduced within CDS
Cj0654c pseudogene (putative transmembrane transport protein) Features introduced within CDS
Cj0676 pseudogene (potassium-transporting ATPase A chain) Features introduced within CDS
Cj0678 pseudogene (potassium-transporting ATPase C chain) Features introduced within CDS
Cj0742 pseudogene (putative outer membrane protein) Features introduced within CDS
Cj0752 pseudogene (IS element transposase) Features introduced within CDS
Cj0866 pseudogene (arylsulfatase) Features introduced within CDS
Cj0969 pseudogene (putative periplasmic protein) Merging of multiple CDS
Cj1064 pseudogene (nitroreductase) Features introduced within CDS
Cj1389 pseudogene (putative C4-dicarboxylate anaerobic carrier) Features introduced within CDS
Cj1395 pseudogene (putative MmgE/PrpD family protein) Unmodified
Cj1470c pesudogene (type II protein secretion system F protein) Features introduced within CDS
Cj1528 pseudogene (putative C4-dicarboxylate anaerobic carrier) Features introduced within CDS
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The significance of pseudogenes in early genome annota-
tions were frequently ignored, as these were considered as
sequencing artefacts. However, given the recent realisa-
tion of the importance of pseudogenes in pathoadaptive
mutations, a greater significance is placed on their identi-
fication [26,29]. An example of this is the re-analysis of
Escherichia coli K-12, which has predicted an additional
161 from the original single pseudogene identified [28].
The same study also indicated pseudogenes are continu-
ally generated, with existing pseudogenes being elimi-
nated over a period of time [28]. Pseudogenes can
accumulate in the genomes of some bacterial species,
especially those undergoing processes like niche adapta-
tion, host specialisation or weak selection strength [30].
Analysis of further Campylobacter strains and species along
with additional epsilon proteobacteria species will aid our
understanding on this emerging area of interest. Also,
greater understanding of pseudogene dynamics and in
particular innovative pseudogene identification tech-
niques will yield more information about the actual
number and purpose of these entities within microorgan-
isms.
Phase-variable CDSs containing hypervariable regions
were also analysed. The initial annotation gave a number
of hypervariable sequences found within the C. jejuni
genomic shotgun sequence [4]. These hypervariable
sequences are scattered throughout the genome, however,
there is a large cluster within both the O-linked glycosyla-
tion and capsule loci. Further research on these loci have
illustrated the impact of phase-variation on microorgan-
ism pathogenicity [11,31,32]. Table 4 shows phase-varia-
ble CDSs that have been modified.
Structural modifications
As well as CDS updates, novel features were also added to
the re-annotation. For example, the incorporation of the
recently identified Clustered Regularly Interspaced Short
Palindromic Repeats (CRISPR) regions within Campylo-
bacter [20,33,34]. CRISPR regions are thought to be
mobile elements. In conjunction with this, the three CDSs
upstream of the CRISPR repeats were identified as CRISPR
associated proteins and this concurs with existing CRISPR
structures. To date, there has only been one identified
CRISPR region within C. jejuni and this has now been
incorporated within the genome. As a result, one CDS
(Cj1520) has been removed. This CDS was previously
annotated as having five repeat regions. Thus, the genome
now contains a CRISPR repeat region in place of the
removed CDS.
Additional genome searches included RFAM database
search to discover any non-coding RNAs. This search iden-
tified two new non-coding RNA structures. RFAM
RF00169, a bacterial signal recognition particle (SRP)
RNA, was identified upstream of Cj0046. The SRP is a uni-
versally conserved ribonucleoprotein involved in the co-
translational targeting of proteins to membranes [35,36].
Also, RFAM RF00059 a thiamin pyrophosphate (TPP)
riboswitch (THI element) was identified upstream of
Cj0453 (thiamin biosynthesis protein ThiC). The RFAM
motif is a conserved structure (THI element), involved in
thiamin-regulation [37].
The final step of the re-annotation process was the incor-
poration of Gene Ontology (GO) annotation. GO anno-
tation attempts to link three structured, controlled
vocabularies (ontologies) that describe gene products in
terms of their associated biological processes, cellular
components and molecular functions in a species-inde-
pendent manner [38]. This re-annotation aims to incor-
porate GO annotation using two automated methods.
Upon submission to EBI, the EMBL file will carry a GOA
link that lists the GO annotation identified automatically
by EBI. A second version of GO was generated by perform-
ing a reciprocal FASTA search using RM1221. This was cre-
ated and submitted to GeneDB. GO annotation is a
valuable feature in current annotation techniques that can
expedite systems biology approaches to genome analysis.
Conclusions
In summary, the re-annotation and re-analysis of the C.
jejuni NCTC11168 genome sequence has led to substan-
tial updates across the entire genome, incorporating a vast
amount of research information performed since the orig-
inal annotation in 2000 and also integrating data from
Table 4: Merged phase-variable CDSs in C. jejuni NCTC11168 re-annotation.
Gene Number Product Effect
Cj0031/Cj0032 putative type IIS restriction/modification 
enzyme
Fusion/separation
Cj0170/Cj0171 hypothetical protein Cj0170 Fusion/separation
Cj0628/Cj0629 putative lipoprotein Fusion/separation
Cj1144/Cj1145 hypothetical protein Cj1144c Fusion/separation
Cj1325/Cj1326 putative methyltransferase Fusion/separation
Cj1335/Cj1336 motility accessory factor (function unknown) Fusion/separation
Cj1677/Cj1678 putative lipoprotein Fusion/separation
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additional Campylobacter species and strains. Major
updates include noteworthy modifications to the 4 main
surface structure loci in the genome, 18.2% of genome
product functions being updated and 90.0% of all CDSs
now having additional information. The inclusion of lit-
erature searches and a GO annotation alongside genome
wide structural modifications has resulted in C. jejuni
NCTC11168 being the most comprehensively annotated
Campylobacter genome to date.
Methods
Sequence searches
Manual re-annotation of all previously annotated C. jejuni
NCTC11168 CDSs [4] was carried out based on results
from BLASTP [39] and FASTA [40] sequence comparisons
using non-redundant databases. Re-annotation was
based, wherever possible, on characterised proteins or
genes [4]. Additional functional data was provided by
using the PFAM [41] and PROSITE [42] motif databases.
New searches carried out in this re-annotation included
running RFAM [43] database and also the programs
TMHMM [44] and SIGNALP [45].
Literature & additional searches
This re-annotation included a complete literature search
of all CDS numbers and gene names using PubMed [46],
HighWire Press [47], Scirus [48] and Google Scholar [49].
Artemis software release 8 [50] was used during re-anno-
tation. The re-annotated sequence was submitted to the
EMBL public database and also to GeneDB [51] and
CampyDB [52]. The EMBL file included an 'original' and
'updated' note qualifier, a 'product' qualifier and each
CDS represented with a unique 'locus_tag' qualifier.
Appropriate 'gene' qualifiers were also present. The
GeneDB submission included all the above and extra
qualifiers 'colour' and 'literature'. This re-annotation also
included for the first time a Gene Ontology (GO) annota-
tion of the NCTC11168 genome sequence. This was cre-
ated automatically on submission to EMBL and can be
accessed via the GOA link. A separate GO annotation was
created within GeneDB by carrying out a reciprocal FASTA
comparison with C. jejuni RM1221 and adopting the GO
annotation of orthologous CDSs.
Re-designation of pseudogenes
Advances in genome annotation techniques that were
unavailable during the original annotation have led to
updated interpretation of pseudogenes and phase-varia-
ble CDSs. Using guidance from TBLASTX search results,
we carried out a full re-analysis of all pseudogenes. CDSs
designated as pseudogenes have been updated to reflect
the complete amino acid sequence for the encoded pro-
tein regardless of expression. This has caused differences
from the amino acid sequence of the previous annotation.
Some pseudogene modifications entailed merging two or
more adjacent, in frame CDSs (previously annotated as
separate pseudogene CDSs), to create a single pseudogene
containing internal stop codons. In other cases, pseudog-
ene features were created with multiple coordinates repre-
senting one or more frameshift in the CDS – these had
previously only detailed the start and stop coordinates so
did not reflect the true position of the non-mutated CDS.
In both cases the assignment of coordinates was based on
matches to homologues determined through FASTA
searches.
Re-designation of CDSs with an intersecting 
homopolymeric tract
CDSs containing an intersecting homopolymeric tract
were merged to reflect the complete amino acid sequence
for appropriate genes regardless of phase. This is analo-
gous to the scenario described above for frameshifted
pseudogenes. This modification was carried out for two
CDSs with an intersecting homopolymeric tract. The join-
ing of such CDSs was not undertaken in the original anno-
tation.
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